Immortalized Human Umbilical Vein Endothelial Cells-SV40

Cat.No.: CSC-I9038L

Species: Homo sapiens

Source: Umbilical cord

Morphology: Polygonal

Culture Properties: Adherent

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
  • Documents
Cat.No.
CSC-I9038L
Description
Immortalized Human Umbilical Vein Endothelial Cells-SV40 from Creative Bioarray were developed from human tissue transduced with a lentiviral expression vector containing the SV40 gene. The cell line was continuously cultured for more than 20 passages without showing signs of growth retardation or replicative senescence whereas the parental cells senesced after having reached 4 passages. Immortalized Human Umbilical Vein Endothelial Cells-SV40 (Cat No.: CSC-I9038L) respond to VEGF treatment and form neoangiogenic webs on Matrigel. This cell line is characterized by the homogenous expression of cell-type specific markers such as vWF.
Species
Homo sapiens
Source
Umbilical cord
Recommended Medium
SuperCult® Immortalized Human Umbilical Vein Endothelial Cell Medium (Cat No.: CM-I9038L)
Freezing Medium
Complete medium supplemented with 10% (v/v) DMSO
Culture Properties
Adherent
Morphology
Polygonal
Immortalization Method
SV40 large T antigen
Application
For Research Use Only
Growth Properties
Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2.
Shipping
Dry Ice.
Quality Control
Real Time PCR was used to quantify SV40 gene expression in immortalized cell line.
Storage and Shipping
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.

Note: Never can cells be kept at -20°C.
BioSafety Level
II
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Immortalized human umbilical vein endothelial cells-SV40 (HUVEC/SV40T) are generated by introducing the SV40 large T antigen into primary HUVECs. This confers indefinite proliferative capacity while preserving core endothelial features: CD31/PECAM-1, VE-cadherin, VEGFR2, CD34, von Willebrand factor, and eNOS. Functionally, they respond to VEGF and inflammatory cytokines and support proliferation, migration, tube formation on Matrigel, acetylated LDL uptake, monolayer barrier assays, leukocyte adhesion, and nitric oxide signaling.

Compared with primary HUVECs, HUVEC/SV40T offer a continuous, scalable, and cost-effective source with high batch-to-batch consistency and reduced donor variability. This enables reproducible high-throughput screening, long-term culture, siRNA/CRISPR perturbation, and co-culture studies. They are widely used to model angiogenesis, vascular permeability, inflammation, atherosclerosis, thrombosis, and endothelial dysfunction, and to evaluate anti-angiogenic, anti-inflammatory, and cardiovascular compounds. They also support toxicity testing, target validation, and host–pathogen interaction studies. Because they are immortalized, they overcome supply limitations and ethical concerns associated with repeated primary isolation.

Curcumin Protected CoCl2-Induced Apoptosis and Ferroptosis in Human Umbilical Vein Endothelial Cells

Hypoxia-induced vascular endothelial cell (EC) injury is the main pathologic mechanism for the development of vascular diseases, such as venous thrombosis, heart disease, and cerebral obstruction. Curcumin, the main active component in the rhizome of Curcuma longa, has anti-inflammatory and antioxidant properties. The aim of the study was to elucidate the underlying mechanisms of curcumin's protective effects on endothelial cells.

Cobalt chloride (CoCl2) was used to induce hypoxia in human umbilical vein endothelial cells (HUVECs) in vitro, followed by treatment with curcumin. We found that curcumin can enhance cell proliferation, promote cell cycle progression, decrease MMP1 and MMP13 expression, and increase TIMP-1 expression in CoCl2-induced HUVECs. Meanwhile, curcumin inhibits CoCl2-induced apoptosis, ferroptosis, and mitochondrial damage in HUVECs. Further studies revealed that curcumin exerted endothelial cell protective effects by down-regulating HSPA6 expression. Curcumin exerts a vascular endothelial protective effect on hypoxia-induced apoptosis and mitochondrial damage in HUVECs.

Curcumin Enhances Proliferation and Inhibits Apoptosis in CoCl2-Induced HUVECs.
Fig. 1. Curcumin enhanced proliferation and inhibited apoptosis in CoCl2-induced HUVECs (Ye, Ruihai, et al., 2026).
Inhibition of Ferroptosis and Amelioration of Mitochondrial Collapse by Curcumin in CoCl2-Induced HUVECs.
Fig. 2. Inhibition of ferroptosis and amelioration of mitochondrial collapse by curcumin in CoCl2-induced HUVECs (Ye, Ruihai, et al., 2026).
What are Immortalized Human Umbilical Vein Endothelial Cells (SV40)?

These are endothelial cells derived from the human umbilical vein that have been immortalized using the SV40 large T antigen, allowing for culturing at least 20 passages. They provide a consistent model for endothelial cell research.

What research applications are Immortalized Human Umbilical Vein Endothelial Cells-SV40 suitable for?

Immortalized Human Umbilical Vein Endothelial Cells-SV40 (Cat No.: CSC-I9038L) are ideal for studying vascular biology, angiogenesis, endothelial cell function, inflammation, and shear stress responses. They are also useful for drug testing and endothelial-related disease models.

Can these cells be used for angiogenesis studies?

Yes, these cells are particularly useful for angiogenesis research. They retain critical properties of endothelial cells, such as the ability to form capillary-like structures in vitro, making them an excellent model for studying blood vessel formation and function.

How do these cells compare to primary human umbilical vein endothelial cells (HUVECs)?

While primary HUVECs have a limited lifespan and batch-to-batch variability, the immortalized version -Immortalized Human Umbilical Vein Endothelial Cells-SV40 (Cat No.: CSC-I9038L) provides a stable, reproducible, and long-lasting model, ensuring consistent results over multiple experiments and extended studies.

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products